1. Home
  2. RIVN vs VTRS Comparison

RIVN vs VTRS Comparison

Compare RIVN & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIVN
  • VTRS
  • Stock Information
  • Founded
  • RIVN 2009
  • VTRS 1961
  • Country
  • RIVN United States
  • VTRS United States
  • Employees
  • RIVN N/A
  • VTRS N/A
  • Industry
  • RIVN Auto Manufacturing
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • RIVN Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • RIVN Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • RIVN 13.3B
  • VTRS 12.9B
  • IPO Year
  • RIVN 2021
  • VTRS N/A
  • Fundamental
  • Price
  • RIVN $10.06
  • VTRS $12.83
  • Analyst Decision
  • RIVN Buy
  • VTRS Hold
  • Analyst Count
  • RIVN 23
  • VTRS 3
  • Target Price
  • RIVN $15.67
  • VTRS $13.33
  • AVG Volume (30 Days)
  • RIVN 41.1M
  • VTRS 7.1M
  • Earning Date
  • RIVN 11-07-2024
  • VTRS 11-07-2024
  • Dividend Yield
  • RIVN N/A
  • VTRS 3.74%
  • EPS Growth
  • RIVN N/A
  • VTRS N/A
  • EPS
  • RIVN N/A
  • VTRS N/A
  • Revenue
  • RIVN $4,551,000,000.00
  • VTRS $15,048,500,000.00
  • Revenue This Year
  • RIVN $7.44
  • VTRS N/A
  • Revenue Next Year
  • RIVN $18.95
  • VTRS N/A
  • P/E Ratio
  • RIVN N/A
  • VTRS N/A
  • Revenue Growth
  • RIVN 20.33
  • VTRS N/A
  • 52 Week Low
  • RIVN $8.26
  • VTRS $9.08
  • 52 Week High
  • RIVN $24.62
  • VTRS $13.62
  • Technical
  • Relative Strength Index (RSI)
  • RIVN 45.27
  • VTRS 62.35
  • Support Level
  • RIVN $9.50
  • VTRS $11.33
  • Resistance Level
  • RIVN $13.10
  • VTRS $13.09
  • Average True Range (ATR)
  • RIVN 0.71
  • VTRS 0.43
  • MACD
  • RIVN 0.09
  • VTRS 0.10
  • Stochastic Oscillator
  • RIVN 15.56
  • VTRS 71.09

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: